Disease | central retinal vein occlusion |
Symptom | C1621353|serous macular detachment |
Sentences | 1 |
PubMedID- 25640801 | Intravitreal bevacizumab: a viable treatment for bilateral central retinal vein occlusion with serous macular detachment secondary to waldenstrom macroglobulinaemia. |
Page: 1